Comment: Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience
Dear Editor, (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Maria Saltari, Giacomo Corrado, Lodovico Patrizi, Enrico Vizza Source Type: research
“Liver-first” approach with ALPPS: The natural combination of two new concepts in liver surgery
Modern colorectal liver metastasis (CRLM) surgery has undergone a very impressive development over the last ten years due to the evolution of methods, techniques and extension of surgical indications. The main limits of surgical CRLM treatment were extension of liver disease, volume and quality of future liver remnant and foreseeable hypertrophy induced by portal vein embolisation or ligation (PVE/PVL) for a possible two-staged hepatectomy. In 2007 Dr. Schlitt, performing the first associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) [1], unconsciously opened Pandora ’s box; leading to inten...
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Marcello Donati, Gregor A. Stavrou, Axel Stang, Francesco Basile, Karl J. Oldhafer Tags: Commentary Source Type: research
Letter-to-the-Editor “Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature” by Tinelli R et al. (Surgical Oncology 25 (2016) 98–103)
We read with great interest the results of the study performed by Tinelli et al. “Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature” in the recent edition of Surgical Oncology [1]. The authors present data of a retrospective case control study of 110 patients who underwent laparoscopic surgery with or without the use of a uterine manipulator for clinical early stage endometrial cancer. They conclude that the use of a uterine manipulator does not increase the rate of positive peritoneal cytology, LVSI and recurrence. (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Louis J.M. van der Putten, Tim Wollinga, Johanna M.A. Pijnenborg Source Type: research
Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy
In this study, one hundred and ninety-two CRC patients were enrolled. The expression of let-7a-5p and HMGA2 in serum and tumour tissues were analysed by real-time PCR and immunohistochemistry. (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Tsang-Pai Liu, Chi-Chou Huang, Ken-Tu Yeh, Tao-Wei Ke, Po-Li Wei, Ji-Rui Yang, Ya-Wen Cheng Source Type: research
Tamoxifen enhances the cytotoxicity of conventional chemotherapy in esophageal adenocarcinoma cells
Esophageal adenocarcinoma is a lethal malignancy which is increasing in incidence, and many patients receive chemotherapy as part of their treatment. We have previously demonstrated that esophageal adenocarcinoma-derived cell lines respond to treatment with estrogen receptor modulators, such as tamoxifen. Reports from breast cancer suggest that tamoxifen may attenuate the efficacy of other chemotherapeutic agents. We have therefore assessed the response of esophageal adenocarcinoma cell lines to tamoxifen therapy when given in combination with conventional agents. (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: S.L. Due, D.I. Watson, I. Bastian, G.Q. Ding, O.A. Sukocheva, D.St.J. Astill, L. Vat, D.J. Hussey Source Type: research
Comment: Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience
Dear Editor, (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Maria Saltari, Giacomo Corrado, Lodovico Patrizi, Enrico Vizza Source Type: research
“Liver-first” approach with ALPPS: The natural combination of two new concepts in liver surgery
Modern colorectal liver metastasis (CRLM) surgery has undergone a very impressive development over the last ten years due to the evolution of methods, techniques and extension of surgical indications. The main limits of surgical CRLM treatment were extension of liver disease, volume and quality of future liver remnant and foreseeable hypertrophy induced by portal vein embolisation or ligation (PVE/PVL) for a possible two-staged hepatectomy. In 2007 Dr. Schlitt, performing the first associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) [1], unconsciously opened Pandora's box; leading to intense ...
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Marcello Donati, Gregor A. Stavrou, Axel Stang, Francesco Basile, Karl J. Oldhafer Tags: Commentary Source Type: research
Letter-to-the-Editor “Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature” by Tinelli R et al. (Surgical Oncology 25 (2016) 98–103)
We read with great interest the results of the study performed by Tinelli et al. “Laparoscopic treatment of early-stage endometrial cancer with and without uterine manipulator: Our experience and review of literature” in the recent edition of Surgical Oncology [1]. The authors present data of a retrospective case control study of 110 patients who underwent laparoscopic surgery with or without the use of a uterine manipulator for clinical early stage endometrial cancer. They conclude that the use of a uterine manipulator does not increase the rate of positive peritoneal cytology, LVSI and recurrence. (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Louis J.M. van der Putten, Tim Wollinga, Johanna M.A. Pijnenborg Source Type: research
Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy
In this study, one hundred and ninety-two CRC patients were enrolled. The expression of let-7a-5p and HMGA2 in serum and tumour tissues were analysed by real-time PCR and immunohistochemistry. (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: Tsang-Pai Liu, Chi-Chou Huang, Ken-Tu Yeh, Tao-Wei Ke, Po-Li Wei, Ji-Rui Yang, Ya-Wen Cheng Source Type: research
Tamoxifen enhances the cytotoxicity of conventional chemotherapy in esophageal adenocarcinoma cells
Esophageal adenocarcinoma is a lethal malignancy which is increasing in incidence, and many patients receive chemotherapy as part of their treatment. We have previously demonstrated that esophageal adenocarcinoma-derived cell lines respond to treatment with estrogen receptor modulators, such as tamoxifen. Reports from breast cancer suggest that tamoxifen may attenuate the efficacy of other chemotherapeutic agents. We have therefore assessed the response of esophageal adenocarcinoma cell lines to tamoxifen therapy when given in combination with conventional agents. (Source: Surgical Oncology)
Source: Surgical Oncology - May 26, 2016 Category: Surgery Authors: S.L. Due, D.I. Watson, I. Bastian, G.Q. Ding, O.A. Sukocheva, D.St.J. Astill, L. Vat, D.J. Hussey Source Type: research
Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery
Surgery is the only modality of cure in patients diagnosed with neuroendocrine tumours (NETs). The aim of this study was to identify prognostic factors associated with disease relapse in patients with NETs treated by potentially-curative surgery. (Source: Surgical Oncology)
Source: Surgical Oncology - May 24, 2016 Category: Surgery Authors: A.E. Slagter, D. Ryder, B. Chakrabarty, A. Lamarca, R.A. Hubner, W. Mansoor, D.A. O ’Reilly, P.E. Fulford, H.J. Klümpen, J.W. Valle, M.G. McNamara Source Type: research
Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study
We aimed to identify prognostic factors of early-stage cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC) treated with primary radical surgery, and to evaluate the impact of postoperative adjuvant therapy on outcome. (Source: Surgical Oncology)
Source: Surgical Oncology - May 24, 2016 Category: Surgery Authors: Nae-Fang Twu, Yu-Che Ou, Cheng-I. Liao, Wei-Yang Chang, Lan-Yan Yang, Yun-Hsin Tang, Tze-Chien Chen, Chi-Hau Chen, Tze-Ho Chen, Lain-Shung Yeh, Shih-Tien Hsu, Yu-Chieh Chen, Cheng-Chang Chang, Ya-Min Cheng, Chia-Yen Huang, Fu-Shing Liu, Yue-Shan Lin, Shen Tags: Review Source Type: research
Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery
Surgery is the only modality of cure in patients diagnosed with neuroendocrine tumours (NETs). The aim of this study was to identify prognostic factors associated with disease relapse in patients with NETs treated by potentially-curative surgery. (Source: Surgical Oncology)
Source: Surgical Oncology - May 24, 2016 Category: Surgery Authors: A.E. Slagter, D. Ryder, B. Chakrabarty, A. Lamarca, R.A. Hubner, W. Mansoor, D.A. O'Reilly, P.E. Fulford, H.J. Klümpen, J.W. Valle, M.G. McNamara Source Type: research
Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study
We aimed to identify prognostic factors of early-stage cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC) treated with primary radical surgery, and to evaluate the impact of postoperative adjuvant therapy on outcome. (Source: Surgical Oncology)
Source: Surgical Oncology - May 24, 2016 Category: Surgery Authors: Nae-Fang Twu, Yu-Che Ou, Cheng-I. Liao, Wei-Yang Chang, Lan-Yan Yang, Yun-Hsin Tang, Tze-Chien Chen, Chi-Hau Chen, Tze-Ho Chen, Lain-Shung Yeh, Shih-Tien Hsu, Yu-Chieh Chen, Cheng-Chang Chang, Ya-Min Cheng, Chia-Yen Huang, Fu-Shing Liu, Yue-Shan Lin, Shen Tags: Review Source Type: research
Prognostic factors of gingival-alveolar squamous cell carcinoma of the maxilla
To determine prognostic factors in gingivo-alveolar squamous cell carcinoma of the maxilla (GA-SCC-M), and particularly the prognostic value of both vertical and antero-posterior tumor spread. (Source: Surgical Oncology)
Source: Surgical Oncology - May 23, 2016 Category: Surgery Authors: A. Morice, A. Ostertag, M. Sahli-Amor, P. Goudot, C. Bertolus, T. Schouman Tags: Review Source Type: research
